Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Hind.Organ.Chem.
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 194 | 145 | 189 | 187 | 183 | 59 | 175 | 165 | 137 | 164 | 126 | 147 | 136 |
| Expenses + | 177 | 154 | 177 | 190 | 183 | 83 | 175 | 191 | 173 | 177 | 143 | 151 | 120 |
| Operating Profit | 16 | -9 | 11 | -3 | -1 | -24 | 0 | -26 | -37 | -13 | -17 | -4 | 17 |
| OPM % | 8% | -6% | 6% | -2% | -0% | -40% | 0% | -16% | -27% | -8% | -14% | -2% | 12% |
| Other Income + | -5 | 3 | 5 | 4 | 7 | 5 | 5 | -35 | 551 | 13 | 5 | 5 | 4 |
| Interest | 17 | 17 | 17 | 18 | 17 | 16 | 18 | 18 | -10 | 5 | 5 | 5 | 5 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Profit before tax | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 523 | -6 | -18 | -4 | 15 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | 0% | 0% | 0% | -7% |
| Net Profit + | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 520 | -6 | -18 | -4 | 16 |
| EPS in Rs | -0.63 | -3.44 | -0.21 | -2.65 | -1.77 | -5.27 | -2.03 | -11.76 | 77.39 | -0.94 | -2.70 | -0.58 | 2.34 |
Financials of Hind.Organ.Chem.
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 | 574 |
| Expenses + | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 | 591 |
| Operating Profit | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 | -18 |
| OPM % | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% | -3% |
| Other Income + | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 | 26 |
| Interest | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 20 |
| Depreciation | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 | -14 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | -7% |
| Net Profit + | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 | -13 |
| EPS in Rs | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 | -1.90 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Hind.Organ.Chem.
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 | 964 |
| Borrowings + | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 219 | 285 |
| Other Liabilities + | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 304 | 225 |
| Total Liabilities | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,542 |
| Fixed Assets + | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 | 231 |
| CWIP | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,336 | 1,310 |
| Total Assets | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,542 |
Financials of Hind.Organ.Chem.
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -116 | 46 | 59 | -451 | -160 | -81 | -50 | 10 | -13 | -66 | 631 | -70 |
| Cash from Investing Activity + | 0 | -6 | -0 | 343 | 112 | 164 | 8 | 11 | 7 | 56 | 10 | 12 |
| Cash from Financing Activity + | 104 | -48 | -59 | 179 | 3 | -90 | 52 | -32 | -10 | 6 | -642 | 58 |
| Net Cash Flow | -12 | -8 | 0 | 72 | -45 | -8 | 9 | -11 | -16 | -4 | -1 | -0 |
| Free Cash Flow | -116 | 40 | 59 | -109 | -53 | 75 | -49 | 10 | -14 | -67 | 624 | -72 |
| CFO/OP | 90% | -38% | -37% | 270% | -573% | 139% | -185% | 1,182% | -202% | 6,570% | -733% | 401% |
Financials of Hind.Organ.Chem.
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 | 5 |
| Inventory Days | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 52 | 41 |
| Days Payable | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 | 14 |
| Cash Conversion Cycle | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 24 | 33 |
| Working Capital Days | -744 | -1,311 | -2,729 | 330 | 235 | 79 | -15 | -134 | -159 | -199 | 483 | 440 |
| ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% | -0% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…